Delivery Order SPE2DB22D3004-SPE2DB24FRV08

Award Date 9/12/24
Potential Completion Date 10/3/24
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide VYEPTI 100 MG/ML VIAL/ML pharmaceuticals. The $12,810.12 contract has a completion date of February 23, 2024. AmerisourceBergen Drug Corp, a for-profit organization, serves as the prime contractor and provides a wide range of pharmaceutical products and medical supplies to the Department of...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The $3,202.53 firm-fixed-price delivery order is for the supply of VYEPTI 100 MG/ML VIAL medication, with a period of performance through October 8, 2024. Amerisourcebergen is one of the largest pharmaceutical distributors in the U.S. and has been awarded numerous contracts by DLA and other federal agencies to provide a wide range of...
This federal contract award is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract, valued at $42,700.40, is for the provision of VYEPTI 100 MG/ML pharmaceutical vials. The delivery order has a completion date of March 14, 2024. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp, through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $46,287.20 firm fixed-price contract is for the supply of VYEPTI 100 MG/ML VIALML, a medication, with a performance period ending on February 21, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract provides for the delivery of VYEPTI 100 MG/ML VIALML, a specialty pharmaceutical product, with a total value of $8,540.08 and a performance period through April 24, 2024. Amerisourcebergen Drug Corp is an experienced prime contractor for DLA, holding an indefinite delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VYEPTI 100 MG/ML VIALML. The contract has a firm fixed price, with a ceiling value of $46,287.20 and a period of performance ending on June 12, 2025. AmerisourceBergen Drug Corp is the prime contractor, and the contract is not set aside. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $6,405.06 order is for the supply of VYEPTI 100 MG/ML VIALML, a pharmaceutical product. The order has a completion date of January 25, 2024. Amerisourcebergen Drug Corp has previously received numerous federal contract awards from DLA to provide pharmaceutical products and medical supplies in support of the agency's programs....
This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,628.72 firm fixed price contract is for the supply of VYEPTI 100 MG/ML VIALML, with a performance period ending on July 14, 2025. Amerisourcebergen Drug Corp is not a small business, as the contract is not set aside. The company holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $2,135.02 firm fixed price delivery order is for the supply of VYEPTI 100 MG/ML VIALML, a pharmaceutical product. The contract has a completion date of January 25, 2024 and was awarded on January 3, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp, as the prime contractor, has a...
The U.S. government agency Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract (SPE2DX15D1053|SPE2DX24F6HYK) valued at $19,215.18 to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of VYEPTI 100 MG/ML VIALML pharmaceuticals. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB24FRV08
    Delivery Order

This is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The $16,012.65 fixed-price contract is for the supply of VYEPTI 100 MG/ML vials. AmerisourceBergen, a large pharmaceutical distributor, is a major supplier of medical products and medications to federal agencies through various Indefinite Delivery Contracts, including a $999,999,999 DLA contract and a $750,000 Department of Justice contract. This award does not have a set-aside designation and is scheduled for completion by October 3, 2024.

Generated 12/12/24, 9:32 AM